Enhancing the efficacy of viral vector blood-stage malaria vaccines
<p>Replication-deficient adenovirus (Ad) and modified vaccinia virus Ankara (MVA) vectors expressing single Plasmodium falciparum antigens can induce potent T cell and antibody responses and have entered clinical testing using a heterologous prime-boost immunisation approach (Ad_MVA). This the...
Autor Principal: | Forbes, E |
---|---|
Outros autores: | Hill, A |
Formato: | Thesis |
Idioma: | English |
Publicado: |
2011
|
Subjects: |
Títulos similares
-
Pre-clinical development of viral vectored transmission-blocking malaria vaccines
por: Kapulu, MC
Publicado: (2014) -
Developing novel blood-stage malaria vaccines
por: Douglas, AD
Publicado: (2015) -
Malaria pre-erythrocytic stage vaccines: targeting antigen combinations
por: Bauza, K
Publicado: (2012) -
Towards improved blood-stage malaria vaccines: characterising the underlying immunogenicity of vaccine adjuvants and vectors
por: de Cassan, S
Publicado: (2011) -
Analysis of b cell responses to blood-stage malaria antigens in humans following immunization with candidate vaccines and controlled human malaria infection
por: Elias, SC
Publicado: (2014)